Pharmacoeconomic advantages of oral minocycline for the therapy of methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infections (SSTIs).

Cunha, B A

Cunha, B A.

Affiliation

Cunha BA; Infectious Disease Division, Winthrop-University Hospital, 222 Station Plaza North (Suite #432), Mineola, NY, 11501, USA, bacunha@winthrop.org.

Eur J Clin Microbiol Infect Dis ; 33(10): 1869-71, 2014 Oct.

Article in En | MEDLINE | ID: mdl-24838676

Subject(s)

Anti-Bacterial Agents/economics; Methicillin-Resistant Staphylococcus aureus/isolation & purification; Soft Tissue Infections/drug therapy; Soft Tissue Infections/economics; Staphylococcal Skin Infections/drug therapy; Staphylococcal Skin Infections/economics; Female; Humans; Male

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Staphylococcal Skin Infections / Soft Tissue Infections / Methicillin-Resistant Staphylococcus aureus / Anti-Bacterial Agents Limits: Female / Humans / Male Language: En Journal: Eur J Clin Microbiol Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS / MICROBIOLOGIA Year: 2014 Document type: Article Country of publication: Germany

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google